D. Rubino

发表论文 71 篇 · 总被引 6819 次 · h-index 27

代表论文

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. (2022 · Journal of the American Medical Association (JAMA) · 被引 833)
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. (2023 · The Lancet · 被引 304)
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. (2025 · New England Journal of Medicine · 被引 150)
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses (2022 · Diabetes, obesity and metabolism · 被引 109)
Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials (2022 · EClinicalMedicine · 被引 80)
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. (2025 · New England Journal of Medicine · 被引 78)